Fosun International Ltd 2018 AR2
The report highlights Fosun International Limited's steady growth in 2018 despite global market uncertainties, driven by its 'Industry Operations + Industrial Investment' model. The company accelerated its C2M happiness ecosystem across health, happiness, and wealth sectors, achieving its seventh consecutive year of profit growth. Key milestones included the successful listing of FTG and Babytree, and the completion of Yuyuan's asset reorganization. Fosun also advanced its technology and innovation investments, notably with Shanghai Henlius's biosimilar approval, and continued its commitment to social responsibility through the 'Rural Doctors' program.
Company: Fosun International Ltd
Sector: Finance & insurance
Country: Hong Kong
Year: 2018
Type: AR2
Pages: 327
Back to company
Fosun International Ltd
Annual Report
The report highlights Fosun International Limited's steady growth in 2018 despite global market uncertainties, driven by its 'Industry Operations + Industrial Investment' model. The company accelerated its C2M happiness ecosystem across health, happiness, and wealth sectors, achieving its seventh consecutive year of profit growth. Key milestones included the successful listing of FTG and Babytree, and the completion of Yuyuan's asset reorganization. Fosun also advanced its technology and innovation investments, notably with Shanghai Henlius's biosimilar approval, and continued its commitment to social responsibility through the 'Rural Doctors' program.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Jan 1, 2018 - Dec 31, 2018
Fiscal Year
2018
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Workplace Fatalities
Employees